ThermoField Diagnostics

Infectious disease detection in a snap

What We Do

Detection of infectious diseases in the field just got easier. A closed-system requiring minimal resources can identify leishmaniasis and soon other infectious diseases with unprecedented mobility. This first of its kind diagnostics toolset will revolutionize field work.

The Product

  • [PROTOTYPE] In-field target specific process stage consumable for infectious disease testing using isothermal amplification techniques
  • [IDEATION] Expand testing panel to additional infectious and non-infectious diseases using DNA targets
  • [IDEATION] Expand tests to include RNA virus detection

Target Customer Pain Points

  • High fidelity diagnostics are hard to come by in the field
  • Contamination of samples decreases confidence in results
  • Consistent power sources, equipment repair costs, and transport/ logistics
    challenges have inhibited use of sophisticated lab equipment
  • The US Army, Medical Facilities in underserved areas, and Global Health Initiatives can take advantage of easy-to-use, low cost solutions


  • Closed-system decreases contamination risk for the patient sample and minimizes clinician/technician exposure to infectious agents
  • Designed specifically for resource-limited environments.
  • Improved sample stabilization within the closed and field-ready system

Market Size

The global market for infectious disease diagnostics alone is projected to reach $18 billion by 2019, a CAGR of 7.9%. More specifically, the Rapid Diagnostic Test (RDT) market is expected to grow at a CAGR of 4.1%

Progress & Milestones

  • Multi-generation prototypes tested and validated
  • Continue benchmark testing against current “gold standards” such as PCR
  • Continue clinical validation to substantiate results relative to other closest
  • Identify manufacturers to produce and scale field-ready materials

Management Team

  • Peter Melby, PhD
  • Bruno Travi, PhD
  • Alexander Vo, PhD
  • Scott Moen, PhD
Download this document